Sign in
TerminatedNo phase

Impact of Pharmaceutical Interviews on the Medication Adherence of Epileptic Patients

Key facts

Who runs it
University Hospital, Lille
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
51 people enrolled
Started
1 Oct 2021
Ended
1 Oct 2024
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Pharmacist intervention
  • Standard of care
Record updated
29 May 2025
Why it stopped
Sponsor's decesion, no inclusion since august 2022

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Epileptic patients seeing a neurologist in the neurophysiology clinic with a regular follow-up by the Lille University Hospital reference center
  • Adult over 18 years old
  • Living at home
  • Socially insured patient
  • In the case of cognitive problems, the presence of a reliable caregiver managing the medications

Who cannot take part

  • Patient who has participated in a therapeutic education program (TEP) about his epilepsy within the previous two years
  • Dementia
  • Inpatients
  • Patient under curatorship, guardianship and/or institutionalized
  • Administrative reasons: impossibility to receive informed information, impossibility to participate in the entire study, lack of coverage by the social security system, refusal to sign the consent form
  • Switching to home care by a registered nurse for treatment management

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Many studies have reported a disparity in medication adherence among epileptic patients. In this population, Medication Possession Ratio (MPR) is an index of medication adherence. MPR is defined as the ratio of the number of days of treatment delivered to the number of days in the period of interest.

Read full original descriptionShow less

No-adherents patients are defined by a MPR of less than 80% , in whom an increase in seizures and the rate of hospitalization can be observed. A pharmacist-led intervention and medication information to epileptic patients could improve patient medication adherence to antiepileptic drugs, and possibly decrease the frequency of seizures, hospitalizations and the health costs generated by these hospitalizations. This intervention could also improve patient knowledge about their medications.

The aim of this study is to evaluate the effectiveness of a pharmacist-led intervention on medication adherence of epileptic patients with the MPR. Secondary objectives include the comparison of medication adherence with health insurance score, the evaluation of patients knowledges about their medications, community pharmacists' satisfaction about community hospital network, the comparison of the seizure free patient rate and the comparison of the rate of patient in whom seizure have decreased by 50%

The 2 groups in the trial

  • Pharmacist-led interventionTreatment being tested

    Treatment: Pharmacist intervention

  • Standard of careSham treatment, for comparison

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Study of the Impact of Pharmaceutical Interventions on the Medication Adherence of Epileptic Patients and Their Medication Knowledge
Record updated
29 May 2025